Aethlon Historical Income Statement
| AEMD Stock | USD 0.37 0 0.27% |
Historical analysis of Aethlon Medical income statement accounts such as Other Operating Expenses of 13.3 M, Total Operating Expenses of 12.9 M or Income Tax Expense of 2.85 can show how well Aethlon Medical performed in making a profits. Evaluating Aethlon Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Aethlon Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Aethlon Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aethlon Medical is a good buy for the upcoming year.
Aethlon |
About Aethlon Income Statement Analysis
Aethlon Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Aethlon Medical shareholders. The income statement also shows Aethlon investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Aethlon Medical Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Aethlon Medical. It is also known as Aethlon Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Aethlon Medical financial statement analysis. It represents the amount of money remaining after all of Aethlon Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Cost Of Revenue
Cost of Revenue is found on Aethlon Medical income statement and represents the costs associated with goods and services Aethlon Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Aethlon Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Other Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 12.9 M, whereas EBIT is projected to grow to (11.6 M).
Aethlon Medical income statement Correlations
Click cells to compare fundamentals
Aethlon Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aethlon Medical income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 54.2K | 1.6K | 123.7K | 131.1M | 150.8M | 158.4M | |
| Other Operating Expenses | 6.6M | 8.5M | 10.7M | 12.6M | 12.6M | 13.3M | |
| Operating Income | (5.9M) | (7.9M) | (10.4M) | (11.9M) | (12.6M) | (12.0M) | |
| Ebit | (5.9M) | (7.9M) | (10.4M) | (11.9M) | (12.2M) | (11.6M) | |
| Ebitda | (5.9M) | (7.8M) | (10.3M) | (11.7M) | (11.8M) | (11.3M) | |
| Total Operating Expenses | 6.6M | 8.5M | 10.7M | 12.6M | 12.3M | 12.9M | |
| Net Income | (6.4M) | (7.8M) | (10.4M) | (12.0M) | (12.2M) | (11.6M) | |
| Income Tax Expense | 48.1K | (43.1K) | (4.8K) | 131.1M | 3.0 | 2.85 | |
| Depreciation And Amortization | 26.4K | 39.9K | 123.7K | 240.9K | 359.1K | 377.0K | |
| Gross Profit | 650.2K | 659.1K | 294.2K | 308.9K | (359.1K) | (377.0K) | |
| Cost Of Revenue | 2.3B | 3.5B | 4.6B | 265.3K | 359.1K | 341.1K | |
| Income Before Tax | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (12.2M) | (12.8M) | |
| Total Other Income Expense Net | (450.1K) | (1.6K) | 4.8M | (131.1K) | 428.4K | 449.8K | |
| Selling General Administrative | 6.6M | 8.5M | 10.7M | 7.5M | 7.4B | 7.8B | |
| Research Development | 927K | 2.1M | 2.3M | 2.7M | 2.5M | 2.6M | |
| Total Revenue | 229.6K | 650.2K | 659.1K | 294.2K | 574.2K | 0.0 | |
| Net Income From Continuing Ops | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (12.2M) | (11.6M) | |
| Net Income Applicable To Common Shares | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (10.8M) | (11.4M) | |
| Minority Interest | (6.1K) | (136.9K) | 4.8K | 620.0 | 713.0 | 748.65 | |
| Interest Income | 220.5K | 54.2K | 0.0 | 11.0K | 428.4K | 243.0K | |
| Net Interest Income | (54.2K) | (1.6K) | 0.0 | 11.0K | 428.4K | 449.8K | |
| Reconciled Depreciation | 26.4K | 39.9K | 123.7K | 240.9K | 359.1K | 377.0K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.79) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.50) | Return On Equity (1.05) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.